Beckwith-Wiedemann syndrome and Wilms' tumour

Molecular Human Reproduction

Volumn 3, Issue 2, 1997, Pages 157-168

  Ward, Andrew ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Genomic imprinting; Hyperplasia; Insulin like growth factor; Simpson Golabi Behmel syndrome; Tumour suppressor

Indexed keywords

SOMATOMEDIN B;

BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11; GENETICS; GENOME IMPRINTING; GROWTH DISORDER; HUMAN; KIDNEY TUMOR; MUTATION; NEPHROBLASTOMA; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

BECKWITH-WIEDEMANN SYNDROME; CHROMOSOMES, HUMAN, PAIR 11; GENES, WILMS TUMOR; GENOMIC IMPRINTING; GROWTH DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MUTATION; WILMS TUMOR;

EID: 0031062973     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (195)

1. Armstrong, J.F., Pritchard-Jones, K., Bickmore, W.A. et al. (1992) The expression of the Wilms' tumour gene, WTI, in the developing mammalian embryo. Mech. Dev., 40, 85-97.
2. Armstrong, J.F., Kaufman, M.H., Harrison, D.J. and Clarke, A.R. (1995) High frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5, 931-936.
3. Baccarini, P., Fiorentino, M., D'Errico, A. et al. (1993) Detection of antisense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor. Am. J. Pathol., 143, 1535-1542.
4. Baird, P.N., Pritchard, J. and Cowell, J.K. (1994) Molecular-genetic analysis of chromosome 11p in familial Wilms-tumor. Br. J. Cancer, 69, 1072-1077.
5. Baker, J., Liu, J., Robertson, L.J. and Efstratiadis, A. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75, 73-82.
6. Bardeesy, N., Falkoff, D., Petruzzi, M.-J. et al. (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet., 7, 91-97.
7. Bartolomei, M.S., Zemel, S. and Tilghman, S.M. (1991) Parental imprinting of the mouse H19 gene. Nature, 351, 153-155.
8. Bartolomei, M.S., Webber, A.L., Brunkow, M.E and Tilghman, S.M. (1993) Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev., 7, 1663-1673.
9. Barton, S.C., Ferguson-Smith, A.C., Fundele, R. and Surani, M.A. (1991) Influence of paternally imprinted genes on development. Development, 113, 679-688.
10. Bates, P., Fisher, R., Ward, A. et al. (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor-II (IGF-II) Br. J. Cancer, 72, 1189-1193.
11. Beckwith, J.B. (1969) Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects, 5, 188-190.
12. Bickmore, W.A., Oghene, K., Little, M.H. et al. (1992) Modulation of DNA binding specificity by alternate splicing of the Wilms tumor wt1 gene transcript. Science, 257, 235-237.
13. Bischoff, F.Z., Feldman, G.L., McCaskill, C. et al. (1995) Single cell analysis demonstrating somatic mosaicism involving 11p in a patient with paternal isodisomy and Beckwith-Wiedemann syndrome. Hum. Mol. Genet., 4, 395-399.
14. Brandeis, M., Kafri, T., Ariel, M. et al. (1993) The ontogeny of allele-specific methylation associated with imprinted senes in the mouse. EMBO J., 12, 3669-3677.
15. Brandon, E.P., Idzerda, R.L. and McKnight, G.S. (1995) Targeting the mouse genome: a compendium of knockouts (part I) Curr. Biol., 5, 625-633.
16. Brannan, C.I., Dees, E.G., Ingram, R.S. and Tilghman, S.M. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36.
17. Brice, A., Cheetham, J.E., Bolton, V.N. et al. (1989) Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. Development, 106, 543-554.
18. Brown, K.W., Williams, J.C., Maitland, N.J. and Mott, M.G. (1990) Genomic imprinting and the Beckwith-Wiedemann syndrome. Am. J. Hum. Genet., 46, 1000-1001.
19. Bruening, W. and Pelletier, J. (1994) Denys-Drash syndrome: a role for the WT1 tumour suppressor gene in urogenital development. Sem. Dev. Biol., 5, 333-343.
20. Buckler, A.J., Pelletier, J., Haber, D.A. et al. (1991) Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol. Cell. Biol. 11, 1707-1712.
21. Call, K.M., Glaser, T., Ito, C.Y. et al. (1990) Isolation and characterisation of a zinc finger polypeptide gene at the human chromosome 11 Wilms' turnor locus. Cell, 60, 509-520.
22. Caricasole, A., Duarte, A., Larsson, S. et al. (1996) RNA binding by the Wilms' tumor suppressor (WT1) zinc finger proteins. Proc. Natl. Acad. Sci. USA, in press
23. Cattanach, B.M. (1986) Parental origin effects in mice. J. Embryol. Exp. Morph., 97 (Suppl.), 137-150.
24. Cattanach, B.M. (1991) Chromosome imprinting and its significance for mammalian development. Genome Anal., 2, 41-71.
25. Cattanach, B.M., Barr, I.A., Evans, E.P. et al. (1992) A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression. Nature Genet., 2, 270-274.
26. Christofori, G., Naik, P. and Hanahan, D. (1994) A second signal supplied by insulin-like growth factor 11 in oncogene-induced tumorigenesis. Nature, 369, 414-417.
27. Christofori, G., Naik, P. and Hanahan, D. (1995) Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumorigenesis. Nature Genet., 10, 196-201.
28. Cideciyan, D., Rodriguez, M.M., Haun, R.L. and Abdenour, G.E. (1993) New findings in short rib syndrome. Am. J. Med. Genet., 46, 255-259.
29. Cowell, J.K. (1994) Genetics of pediatric solid tumors. Br. Med. Bull., 50, 600-623.
30. Cowell, J.K., Wadey, R.B., Haber, D.A. et al. (1991) Structural rearrangements of the WT1 gene in Wilms' tumor cells Oncogene, 6, 595-599.
31. De Souza, A.T., Hankins, G.R., Washington, M.K. et al. (1995) M6P/ IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet., 11, 447-449.
32. DeChiara, T.M., Robertson, E.J. and Efstratiadis, A. (1990) A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature, 345, 78-80.
33. DeChiara, T.M., Efstratiadis, A. and Robertson, E.J. (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 64, 849-859.
34. Dey, B.R., Sukhatme, V.P., Roberts, A.B. et al. (1994) Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol., 8, 595-601.
35. Donehower, L.A., Harvey, M., Slagle, B.L. et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
36. Drummond, I.A., Madden, S.L., Rohwer-Nutter, P. et al. (1992) Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science, 257, 674-678.
37. Drummond, I.A., Rupprecht, H.D., Rohwer-Nutter, P. et al. (1994) DNA recognition by splicing variants of the Wilms' tumor suppressor. WT1. Mol Cell Biol., 14, 3800-3809.
38. Ekstrom, T.J., Cui, H., Li, X. and Ohlsson, R. (1995) Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development, 121, 309-316.
39. Elliott, M., Bayly, R., Cole, T. et al. (1994) Clinical-features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin. Genet., 46, 168-174.
40. Engel, J.D. (1993) Developmental regulation of human β-globin gene transcription a switch of loyalties? Trends Genet., 9, 304-309.
41. Englert, C., Hou, X., Mahaswaran, S. et al. (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14, 4662-4675.
42. Engstrom, W., Lindham, S. and Schofield, P. (1988) Wiedemann-Beckwith syndrome. Eur. J. Pediatr., 147, 450-457.
43. Feil, R., Walter, J., Allen, N.D. and Reik, W. (1994) Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development, 120, 2933-2943.
44. Feinberg, A.P. (1993) Genomic imprinting and gene activation in cancer. Nature Genet., 4, 110-113.
45. Feinberg, A.P. (1994) A developmental context for multiple genetic alterations in Wilms' tumor J. Cell. Sci., 18 (Suppl.), 7-12.
46. Ferguson-Smith, A.C., Sasaki, H., Cattanach, B.M. and Surani, M.A. (1993) Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature, 362, 751-755.
47. Filson, A.J., Louvi, A., Efstradiadis, A. and Robertson, E.J. (1993) Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development, 118, 731-736.
48. Gessler, M., Poustka, A., Cavenee, W. et al. (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778.
49. Giannoukakis, N., Deal, C., Paquette, J. et al. (1993) Parental genomic imprinting of the human IGF2 gene. Nature Genet., 4, 98-101.
50. Giddings, S.J., King, C.D., Harman, K.W. et al. (1994) Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nature Genet., 6, 310-313.
51. Godley, L.A., Kopp, J.B., Eckhaus, M. et al. (1996) Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev., 10, in press.
52. Goodyer, P., Dehbi, M., Torban, E. et al. (1995) Repression of the retinoic acid receptor-α gene by the Wilms' tumor suppressor gene product. wt1. Oncogene, 10, 1125-1129
53. Guillemot, P., Nagy, A., Auerbach, A. et al. (1994) Essential role of Mash2 in extraembryonic development Nature, 371, 333-336.
54. Guillemot, F., Caspary, T., Tilghman, S.M. et al. (1995) Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nature Genet., 9, 235-241.
55. Haber, D.A., Buckler, A.J., Glaser, T. et al. (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61, 1257-1269.
56. Haig, D. (1994) Is human insulin imprinted? Nature Genet., 7, 10.
57. Hall, J.G. (1990) Genomic imprinting: review and relevance to human disease. Am. J. Hum Genet., 46, 857-873
58. Hankins, G.R., De Souza, A.T., Bentley, R.C. et al. (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene, 12, 2003-2009.
59. Hao, Y., Crenshaw, T., Moulton, T. et al. (1993) Tumour-suppressor activity of H19 RNA. Nature, 365, 764-767.
60. Harrington, M.A., Konicek, B., Song, A. et al. (1993) Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem., 268, 2171-2175.
61. Haselbacher, G.K., Irminger, J.-C., Zapf, J. et al. (1987) Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc. Natl. Acad Sci. USA, 84, 1104-1106
62. Hashimoto, K., Azuma, C., Koyama, M. et al. (1995) Loss of imprinting in choriocarcinoma. Nature Genet., 9, 109-110.
63. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genet., 11, 204-206.
64. Hatada, Y. and Stern, C.D. (1994) A fate map of the epiblast of the early chick embryo Development, 120, 2879-2889.
65. Hedborg, F., Holmgren, L., Sandstedt, B. and Ohlsson, R. (1994) The cell-type-specific IGF2 expression during early human-development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am. J. Pathol., 145, 802-817.
66. Henry, B.-P., C., Chenhensse, V., Beldjord, C. et al. (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature, 351, 665-667.
67. Holstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancer. Science, 253, 49-53.
68. Hoovers, J.M.N., Kalikin, L.M., Johnson, L.A. et al. (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl. Acad. Sci. USA, 92, 12456-12460.
69. Hurst, L.D., McVean, G. and Moore, T. (1996) Imprinted genes have few and small introns. Nature Genet, 12, 234-237.
70. Jinno, Y., Ikeda, Y., Yun, K. et al. (1995) Establishment of functional imprinting of the H19 gene in human developing placentae. Nature Genet., 10, 318-324.
71. Johnson, J.A., Aughton, D.J., Comstock, C.H. et al. (1994) Prenatal-diagnosis of Smith-Lemli-Opitz syndrome, type-II. Am. J. Med. Genet., 49, 240-243.
72. Junien, C. (1992) Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr. Opin. Gen. Dev., 2, 431-438.
73. Kittur, S.D., Hoppener, J.W.M., Antonarakis, S.E. (1985) Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II. Proc. Natl. Acad. Sci. USA, 82.
74. Knudson, A.G. and Strong, L.C. (1972) Mutation and cancer: a model for Wilms' tumor of the kidney. J. Natl. Cancer Inst., 48, 313-323.
75. Koi, M., Johnson, L.A., Kalikin, L.M. et al. (1993) Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science, 260, 361-364.
76. Koufos, A., Grundy, P., Morgan, K. et al. (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms' tumour locus both map to 11p15.5. Am J. Hum. Genet., 44, 711-719.
77. Kreidberg, J.A., Sariola, H., Loring, J.M. et al. (1993) WT-1 is required for early kidney development. Cell, 74, 679-691.
78. Larsson, S.H., Charlieu, J.-P., Miyagawa, K. et al. (1995) Subnuclear localisation of WT1 in splicing or transcription domains is regulated by alternative splicing. Cell, 81, 391-401
79. Lau, M.M.H., Stewart, C.E.H., Liu, Z. et al. (1994) Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev., 8, 2953-2963.
80. Lee, J.E., Pintar, J. and Efstratiadis, A. (1990) Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development, 110, 151-159.
81. Lee, J.E., Tantravahi, U., Boyle, A.L. and Efstratiadis, A. (1993) Parental imprinting of an Igf-2 transegne. Mol. Rep. Dev., 35, 382-390.
82. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9, 639-649.
83. Leighton, P.A., Ingram, R.S., Eggenschwiler, J. et al. (1995a) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature, 375, 34-39.
84. Leighton, P.A., Saam, J.R., Ingram, R.S. et al. (1995b) An enhancer deletion affects both H19 and Igf-2 expression. Genes Dev., 9, 2079-2089.
85. Li, E., Beard, C. and Jaenisch, R. (1993) Role for DNA methylation in genomic imprinting. Nature, 366, 362-365.
86. Little, M., Van Heyningen, V. and Hastie, N. (1991) Dads and disomy and disease. Nature, 351, 609-610.
87. Little, M.H., Prosser, J., Condie, A. et al. (1992) Zinc finger point mutations within the WT1 gene in Wilms tumour patients. Proc. Natl. Acad. Sci. USA, 89, 4791-4795.
88. Liu, J., Baker, J., Perkins, A.S. et al. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (IgfIr) Cell, 75, 59-72.
89. Maheswaran, S., Park, S., Bernard, A. et al. (1993) Physical and functional interactions between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA, 90, 5100-5104.
90. Mann, J.R., Gadi, I., Harbison, M.L. et al. (1990) Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genomic imprinting. Cell, 62, 251-260.
91. Mannens, M., Slater, R., Heyting, C. et al. (1988) Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum. Genet., 81, 41-48.
92. Martinerie, C., Chevalier, G., Rauscher III, F.J. and Perbal, B. (1996) Regulation of nov by WT1: a potential role for nov in nephrogenesis. Oncogene, 12, 1479-1492.
93. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9, 650-662.
94. KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA, 93, 3026-3030.
95. McCowan, L.M.E. and Becroft, D.M.O (1994) Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet. Gynecol., 83, 813-817.
96. McGinnis, W. and Krumlauf, R. (1992) Homeobox genes and axial patterning. Cell, 68, 283-302.
97. Morison, I.M., Becroft, D.M., Taniguchi, T. et al. (1996) Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med., 2, 311-316
98. Morton, C.C., Byers, M.G., Nakai, H. et al. (1986) Human genes for insulin-like growth factor-I and factor-II and epidermal growth-factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet. Cell Genet., 41, 245-249.
99. Moulton, T., Crenshaw, T., Hao, Y. et al. (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet., 7, 440-447.
100. Negrini, M., Sabbioni, S., Ohta, M. et al. (1995) Seven megabase yeast artificial chromosome contig at region 11p15: Identification of a yeast artificial chromosome spanning the breakpoint of a chromosomal translocation found in a case of Beckwith-Wiedemann syndrome. Cancer Res., 55, 2904-2909.
101. Newell, S., Ward, A. and Graham, C. (1994) Discriminating translation of insulin-like growth factor II (IGF-II) during mouse embryogenesis. Mol. Rep. Dev., 39, 249-258.
102. Nielsen, F.C., Ostergaard, L., Nielsen, J. and Christiansen, J. (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature, 377, 358-362.
103. Nystrom, A., Engstrom, W., Cheetham, J. and Schofield, P.N. (1992) Molecular analysis of patients with Wiedemann-Beckwith syndrome I. Gene dosage on the short arm of chromosome 11. Eur. J. Pediatr., 151, 504-510.
104. Nystrom, A., Hedborg, F. and Ohlsson, R. (1994) Insulin-like growth factor 2 cannot be linked to a familial form of Beckwith-Wiedemann syndrome. Eur. J. Pediatr., 153, 574-580.
105. Ogawa, O., Becroft, D.M., Morison, I.M. et al. (1993a) Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nature Genet., 5, 408-412.
106. Ogawa, O., Eccles, M.R., Szeto, J. et al. (1993b) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature, 362, 749-751.
107. Ohlsson, R., Nystrom, A., Pfeifer-Ohlsson, S. et al. (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet., 4, 95-97.
108. Ohlsson, R., Hedborg, F., Holmgren, L. et al. (1994) Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development, 120, 361-368.
109. O'Malley, K.L. and Rotwein, P. (1988) Human tyrosine hydroxylase and insulin genes are contiguous on chromosomes 11. Nucleic Acids Res., 16, 4437-4446.
110. Orth, U., Gurrieri, F., Behmel, A. et al. (1994) Gene for Simpson-Golabi-Behmel syndrome is linked to HPRT in Xq26 in two European families. Am. J. Med. Genet., 50, 388-390.
111. Ozcelik, T., Leff, S., Robinson, W. et al. (1992) Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genet., 2, 265-269.
112. Pal, N., Wasdey, R.B., Buckler, B. et al. (1990) Preferential loss of maternal alleles in sporadic Wilms tumor. Oncogene, 5, 1665-1668.
113. Park, S., Bernard, A., Bove, K.E. et al. (1993) Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet., 5, 363-367.
114. Pedone, P.V., Tirabosco, R., Cavazzana, A.O. et al. (1994) Mono- and biallelic expression of insulin-like growth factor II gene in human muscle tumours. Hum. Mol. Genet., 3, 1117-1121.
115. Pelletier, J., Schalling, M., Buckler, A.J. et al. (1991) Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev., 5, 1345-1356.
116. Penny, G.D., Kay, G.F., Sheardown, S.A. et al. (1996) Requirement for Xist in X chromosome inactivation. Nature, 379, 131-137.
117. Pettenati, M.J., Haines, J.L., Higgins, R.R. et al. (1986) Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum. Genet., 74, 143-154.
118. Pilia, G., Hughes-Benzie, R.M., MacKenzie, A. et al. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet., 12, 241-247.
119. Ping, A.J., Reeve, A.E., Law, D.J. et al. (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am. J. Hum. Genet., 44, 720-723.
120. Poirier, F., Chan, C.-TJ., Timmons, P.M. et al. (1991) The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development, 113, 1105-1114.
121. Pritchard-Jones, K., Fleming, S., Davidson, D. et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature, 346, 194-197.
122. Purdie, C.A., Harrison, D.J., Peter, A. et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9, 603-609.
123. Rachmilewitz, J., Goshen, R., Ariel, I. et al. (1992) Parental imprinting of the human H19 gene. FEBS Lett., 309, 25-28.
124. Rainier, S., Johnson, L.A., Dobry, C.J. et al. (1993) Relaxation of imprinted genes in human cancer. Nature, 362, 747-749.
125. Rainier, S., Dobry, C.J. and Feinberg, A.P. (1995) Loss of imprinting in hepatoblastoma. Cancer Res., 55, 1836-1838.
126. Rauscher III, F.J., Morris, J.F., Tournay, O.E. et al. (1990) Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science, 250, 1259-1262.
127. Razin, A. and Cedar, H. (1994) DNA methylation and genomic imprinting. Cell, 77, 473-476.
128. Razin, A. and Shemer, R. (1995) DNA methylation in early development. Hum. Mol. Genet., 4, 1751-1755.
129. Redeker, E., Alders, M., Hoovers, J.M.N. et al. (1995) Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15.3. Cytogenet. Cell Genet., 68, 222-225.
130. Reeve, A.E., Eccles, M.R., Wilkins, R.J. et al. (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature, 317, 258-260.
131. Reeve, A.E., Sih, S.A., Raizis, A.M. and Feinberg, A.P. (1989) Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol. Cell. Biol., 9, 1799-1803.
132. Reid, L.H., West, A., Gioeli, D.G. et al. (1996) Localization of a tumour suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Hum. Mol. Genet., 5, 239-247.
133. Reik, W. (1989) Genomic imprinting and genetic disorders in man. Trends Genet., 5, 331-336.
134. Reik, W., Brown, K.W., Schneid, H. et al. (1995) Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet., 4, 2379-2385.
135. Rogler, C.E., Yang, D., Rossetti, L. et al. (1994) Altered body composition and increased frequency of diverse malignancies in IGF-II transgenic mice. J. Biol. Chem., 269, 13779-13784.
136. Rothenpieler, U.W. and Dressler, G.R. (1993) Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development, 119, 711-720.
137. Rupprecht, H.D., Drummond, I.A., Madden, S.L. et al. (1994) The Wilms' tumor suppressor gene WTI is negatively autoregulated. J. Biol. Chem., 269, 6198-6206.
138. Ryan, G., Steele-Perkins, V., Morris, J.F. et al. (1995) Repression of Pax-2 by WT1 during normal kidney development. Development, 121, 867-875.
139. Sah, V.P., Attardi, L.D., Williams, B.O. et al. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nature Genet, 10, 175-180.
140. Sasaki, H., Jones, P.A., Chaillet, J.R. et al. (1992) Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II gene. Genes Dev., 6, 1843-1856.
141. Schlessinger, J., Lax, I. and Lemmon, M. (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell, 83, 357-360.
142. Schofield, P.N. and Engstrom, W. (1992) Insulin-like growth factors in human cancer. In Schofield, P.N. (ed.), The Insulin-Like Growth Factors. Structure and Biological Functions. Oxford University Press, Oxford, pp. 240-257.
143. Schroeder, W.T., Chao, L.-Y. Dao, D.D. et al. (1987) Non-random loss of maternal chromosome 11 alleles in Wilms tumors. Am. J. Hum. Genet, 40, 413-420.
144. Schulze, A., Hansen, C., Skakkebaek, N.E. et al. (1996) Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nature Genet., 12, 452-454.
145. Scott, J., Cowell, J., Robertson, M.E. et al. (1985) Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature, 317, 260-262.
146. Sell, C., Rubini, M., Rubin, R. et al. (1993) Simian virus-40 large tumor-antigen is unable to transform mouse embryonic fibroblasts lacking type-1 insulin-like growth-factor receptor. Proc. Natl. Acad Sci. USA. 90, 11217-11221.
147. Sell, C., Duminel, G., Deveaud, C. et al. (1994) Effect of a null mutation of the insulin-like growth-factor-I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14, 3604-3612.
148. Shapiro, L.R., Duncan, P.A., Davidian, M.M. and Singer, N. (1982) The placenta in familial Beckwith-Wiedemann syndrome. Birth Defects. 18, 203-206.
149. Slater, R.M. and Mannens, M.M.A.M. (1992) Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet. Cytogenet., 61, 111-121.
150. Slatter, R.E., Elliott, M., Welham, K. et al. (1994) Mosaic uniparental disomy in Beckwith-Wiedemann syndrome. J. Med. Genet., 31, 749-753.
151. Soares, M.B., Schon, E., Henderson, A. et al. (1986) RNA-mediated gene duplication: The rat preproinsulin 1 gene is a functional retroposon. Mol. Cell Biol., 5, 2090-2103.
152. Steenman, M.J.C., Rainier, S., Dobry, C.J. et al. (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of HI9 in Wilms' tumour Nature Genet., 7, 433-439.
153. Stoger, R., Kubicka, P., Liu, C-G. et al. (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinted signal. Cell, 73, 61-71.
154. Sturgis, E.M. and Howell, L.L. (1995) Bifid epiglottis syndrome. Int. J. Pediat. Otorhinolaryngol., 33, 149-157.
155. Sutcliffe, J.S., Nakao, M., Christian, S. et al. (1994) Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genet., 8, 52-58.
156. Suzuki, H., Ueda, R., Takahashi, T. and Takahashi, T. (1994) Altered imprinting in lung cancer. Nature Genet., 6, 332-333.
157. Tadokoro, K., Fujii, H., Ohshima, A. et al. (1992) Intragenic homozygous deletions of the WTI gene in Wilms' tumor. Oncogene, 7, 1215-1221.
158. Taniguchi, T., Sullivan, M.J., Ogawa, O. and Reeve, A.E. (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl. Acad. Sci. USA, 92, 2159-2163.
159. Torres, M., Gomezpardo, E., Dressler, G.R. and Gruss, P. (1995) Pax-2 controls multiple steps of urogenital development. Development, 121, 4057-4065.
160. Tremblay, K.D., Saam, J.R., Ingram, R.S. et al. (1995) A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nature Genet., 9, 407-413.
161. Trojan, J., Johnson, R., Rudin, S.D. et al. (1993) Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science, 259, 94-97.
162. Urioste, M., Rodriguez, J.I., Barcia, J.M. et al. (1993) Persistence of Mullerian derivatives, lymphangiectasis, hepatic failure, postaxial polydactyly, renal and crantofacial anomolies. Am J. Med. Genet., 47, 494-503.
163. van Buul-Offers, S.C., de Haan, K., Reijnen-Gresnigt, M.G. et al. (1995) Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J. Endocrinol., 144, 491-502.
164. Van Heyningen, V. and Hastie, N.D. (1992) Wilms' tumour: reconciling genetics and biology. Trends Genet., 8, 16-21.
165. Vangurp, R.J.H.L.M., Oosterhuis, J.W., Kalscheuer, V. et al. (1994) Biallelic expression of the H19 and IGF2 genes in human testicular germ-cell tumours. J. Natl. Cancer Inst., 86, 1070-1075.
166. Varanasi, R., Bardees, N., Ghahremani, M. et al. (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc. Natl. Acad. Sci. USA, 91, 3554-3558.
167. Vazquez, M.P., Vacher, C., Buis, J. et al. (1994) Congenital macroglossia and Beckwith-Wiedemann syndrome: a review of 31 cases. Ann. Ped., 41, 303-315.
168. Vu, T.H. and Huffman, A.R. (1994) Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature, 371, 714-717.
169. Vu, T.H., Yballe, C., Boonyanit, S. and Hoffman, A.R. (1995) Insulin-like growth factor-II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J. Clin. Endocrinol. Metab., 80, 1670-1676.
170. Wadey, R.B., Pal, N., Buckle, B. et al. (1990) Loss of heterozygosity in Wilms-tumor involves two distinct regions of chromosome 11. Oncogene, 5, 901-907.
171. Wang, Z.Q., Fling, M.R., Barlow, D.P. and Wagner, E.F. (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature, 372, 464-467.
172. Wang, Z.Y., Madden, S.L., Deuel, T.F. and Rauscher III, F.J. (1992) The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J.Biol. Chem., 267, 21999-22002.
173. Wang, Z.-Y., Qui, Q.-Q. and Deuel, T.F. (1993) The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J.Biol. Chem., 268, 9172-9175.
174. Wang, Z.-Y., Qiu, Q.-Q., Gurrieri, M. et al. (1995) WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene, 10, 1243-1247.
175. Ward, A. (1997) Functions and expression of the insulin-like growth factors: lessons from transgenic models. J. Endocrinol., (in press).
176. Ward, A. and Ellis, C.J. (1992) The insulin-like growth factor genes. In Schofield, P.N. (ed.), The Insulin-Like Growth Factors: Structure and Biological Functions. Oxford University Press, Oxford, pp. 45-79.
177. Ward, A., Bates, P., Fisher, R. et al. (1994a) Disproportionate growth in mice with Igf-2 transgenes. Proc. Natl. Acad. Sci. USA, 91, 10365-10369.
178. Ward, A., Bierke, P., Pettersson, E. and Engstrom, W. (1994b) Insulin-like growth factors: growth, transgenes and imprinting. Zool. Sci., 11, 167-174.
179. Ward, A., Pooler, J.A., Mryagawa, K. et al. (1995) Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1. Gene, 167, 235-243.
180. Weksberg, R., Shen, D.R., Fei, Y.L. et al. (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
181. Weksberg, R., Squire, J.A. and Templeton, D.M. (1996) Glypicans: a growing trend. Nature Genet., 12, 225-227.
182. Wentworth, B.M., Schaefer, I.M., Villa-Komaroff, L. and Chirgwin, J.M. (1986) Characterisation of the two nonallelic genes encoding mouse preproinsulin. J. Mol. Evol. 23, 305-312.
183. Werner, H., Re, G.G., Drummond, I.A. et al. (1993) Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA, 90, 5828-5832.
184. Werner, H., Rauscher III, F.J., Sukhatme, V.P. et al. (1994) Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J. Biol. Chem., 269, 12577-12582.
185. Wiedemann, H.R. (1964) Complexe malformatif familial avec hernie ombilicale et macroglossie: un 'syndrome nouveau'? J. Genet. Hum., 13, 223-232
186. Wiedemann, H.R. (1983) Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur. J. Pediatr., 141, 129.
187. Williams, J.C., Brown, K.W., Mott, M.G. and Maitland, N.J. (1989) Maternal allele loss in Wilms' tumour. Lancet, i, 283-284.
188. Wood, W.D. (1996) The complexities of β-globin gene regulation. Trends Genet., 12, 204-206
189. Xuan, J.Y., Besner, A., Ireland, M. et al. (1994) Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27. Hum. Mol Genet., 3, 133-137.
190. Yun, K., Fidler, A.E., Eccles, M.R. and Reeve, A.E. (1993) Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor. Cancer Res., 53, 5166-5171.
191. Zemel, S., Bartolomei, M.S. and Tilghman, S.M. (1992) Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet., 2, 61-65.
192. Zhan, S., Shapiro, D.N. and Helman, L.J. (1994) Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest., 94, 445-448.
193. Zhang, Y. and Tycko, B. (1992) Monoallelic expression of the human H19 gene. Nature Genet., 1, 40-44.
194. Zhou, Q.-Y, Quaife, C.J. and Palmiter, R.D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature, 374, 640-643.
195. Zlotogora, J., Ariel, I., Ornoy, A. et al. (1996) Thomas syndrome: Potter sequence with cleft-lip palate and cardiac anomolies. Am. J. Med. Genet., 62, 224-226.